381 related articles for article (PubMed ID: 32848363)
1. Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway.
Han J; Pang X; Zhang Y; Peng Z; Shi X; Xing Y
Drug Des Devel Ther; 2020; 14():3223-3234. PubMed ID: 32848363
[TBL] [Abstract][Full Text] [Related]
2. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of dexmedetomidine against renal injury in diabetic nephropathy rats through inhibiting NF-κB pathway.
Liu YT; Liu W; Wan ZH; Wang XQ; Gu FX
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11865-11870. PubMed ID: 33275257
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
5. Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways.
Li J; Bao L; Zha D; Zhang L; Gao P; Zhang J; Wu X
Int Immunopharmacol; 2018 Feb; 55():9-19. PubMed ID: 29207360
[TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
7. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
Guo M; Gao J; Jiang L; Dai Y
Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
[TBL] [Abstract][Full Text] [Related]
8. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
9. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
10. Hirudin reduces nephropathy microangiopathy in STZ-induced diabetes rats by inhibiting endothelial cell migration and angiogenesis.
Pang X; Zhang Y; Peng Z; Shi X; Han J; Xing Y
Life Sci; 2020 Aug; 255():117779. PubMed ID: 32417374
[TBL] [Abstract][Full Text] [Related]
11. The protective effect and mechanism of catalpol on high glucose-induced podocyte injury.
Chen Y; Liu Q; Shan Z; Zhao Y; Li M; Wang B; Zheng X; Feng W
BMC Complement Altern Med; 2019 Sep; 19(1):244. PubMed ID: 31488111
[TBL] [Abstract][Full Text] [Related]
12. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
Li F; Chen Y; Li Y; Huang M; Zhao W
Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
[TBL] [Abstract][Full Text] [Related]
13. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
14. Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy.
Cui FQ; Tang L; Gao YB; Wang YF; Meng Y; Shen C; Shen ZL; Liu ZQ; Zhao WJ; Liu WJ
J Diabetes Res; 2019; 2019():2981705. PubMed ID: 31179339
[TBL] [Abstract][Full Text] [Related]
15. Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress.
Long C; Lin Q; Mo J; Xiao Y; Xie Y
Drug Dev Res; 2022 Jun; 83(4):1047-1056. PubMed ID: 35277865
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways.
Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
BMC Complement Altern Med; 2014 May; 14():156. PubMed ID: 24886259
[TBL] [Abstract][Full Text] [Related]
17. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
BMC Complement Altern Med; 2014 Mar; 14():110. PubMed ID: 24666993
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
[TBL] [Abstract][Full Text] [Related]
19. Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model.
Qiao L; Liu Y; Li C; Ge J; Li T
Pharmacology; 2019; 104(5-6):258-266. PubMed ID: 31344701
[TBL] [Abstract][Full Text] [Related]
20. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
